USAabout provides insights into the profitability of commercial propertise and offers up-tp-date stock market news for informed investment decesion.

Facebook-f Twitter Instagram
Stock Market

Mizuho Securities maintains BridgeBio Pharma at 'buy' with a price target of $60.00

eqed5
eqed5
0 Min Read




Mizuho Securities maintains BridgeBio Pharma at 'buy' with a price target of $60.00

You Might Also Like

Young Mexican governor makes move for next year’s presidential race By Reuters

Northwest Bancshares Non-GAAP EPS of $0.31 beats by $0.07, revenue of $139.26M beats by $5.86M

One FTSE 250 stock investors should consider buying for long-term returns and growth

Important takeaways from Tesla’s Q3 2023 report

Opinion: AI needs a strong code of ethics to keep its dark side from overtaking us

Share this Article
Previous Article SpiceJet Q1 loss: SpiceJet Q1 Results: Airline swings to profit of Rs 198 crore from loss YoY on lower expenses
Next Article I spent 30 years counseling the likes of Tom Brady and Michael Phelps. Here’s how they stay sane in an insane world
Leave a comment

Stay Connected

Latest News

Forrester’s 2024 Technology Strategy Impact Award Winners For EMEA
Market Analysis
Key Takeaways From The Forrester Wave™
Market Analysis
DRÄXLMAIER Group Wins The 15th Annual Enterprise Architecture Award In EMEA
Market Analysis
What Is Top Of Mind For B2B CMOs In Asia-Pacific
Market Analysis
Lost your password?